Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mulligan, Stephen P.
1048  Ergebnisse:
Personensuche X
?
1

Venetoclax-rituximab is active in patients with BTKi-expose..:

Lew, Thomas E. ; Bennett, Rory ; Lin, Victor S....
Blood Advances.  8 (2024)  6 - p. 1439-1443 , 2024
Link: https://doi.org/10.1182/..
 
?
2

The CIpP activator, TR-57, is highly effective as a single ..:

Fatima, Narjis ; Shen, Yandong ; Crassini, Kyle...
Leukemia & Lymphoma.  65 (2024)  5 - p. 585-597 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Chronic lymphocytic leukaemia Australasian consensus practi..:

Anderson, Mary A. ; Bennett, Rory ; Badoux, Xavier...
Internal Medicine Journal.  53 (2023)  9 - p. 1678-1691 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Repeated COVID‐19 vaccination to maximum antibody response ..:

Shen, Yandong ; Freeman, Jane A. ; Kerridge, Ian...
British Journal of Haematology.  204 (2023)  2 - p. 487-491 , 2023
Link: https://doi.org/10.1111/..
 
?
5

BTK and PLCG2 remain unmutated in one-third of patients wit..:

Bonfiglio, Silvia ; Sutton, Lesley-Ann ; Ljungström, Viktor...
Blood Advances.  7 (2023)  12 - p. 2794-2806 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Metastatic squamous cell carcinoma in chronic lymphocytic l..:

Lai, Belinda ; Shen, Yandong ; Guminski, Alexander..
Australasian Journal of Dermatology.  64 (2023)  2 - p. 291-295 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Ibrutinib use, treatment duration, and concomitant medicati..:

Mulligan, Stephen P. ; Opat, Stephen ; Marlton, Paula...
British Journal of Haematology.  198 (2022)  4 - p. 790-793 , 2022
Link: https://doi.org/10.1111/..
 
?
8

Immunoglobulin replacement therapy in chronic lymphocytic l..:

Keegan, Anastazia ; Dennington, Peta M. ; Dhondy, Nina.
European Journal of Haematology.  108 (2022)  6 - p. 460-468 , 2022
Link: https://doi.org/10.1111/..
 
?
9

COVID‐19 vaccine failure in chronic lymphocytic leukaemia a..:

Shen, Yandong ; Freeman, Jane A. ; Holland, Juliette...
British Journal of Haematology.  197 (2022)  1 - p. 41-51 , 2022
Link: https://doi.org/10.1111/..
 
?
10

Real-world experience of Australian and New Zealand patient..:

Mulligan, Stephen P. ; Opat, Stephen ; Cheah, Chan Y....
Leukemia & Lymphoma.  64 (2022)  2 - p. 312-318 , 2022
Link: https://doi.org/10.1080/..
 
?
11

Improving outcomes for patients with lymphoma: design and d..:

Lymphoma and Related Diseases Registry Investigators ; Anderson, Mary Ann ; Berkahn, Leanne...
BMC Medical Research Methodology.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

The ClpP activator ONC‐212 (TR‐31) inhibits BCL2 and B‐cell..:

Fatima, Narjis ; Shen, Yandong ; Crassini, Kyle...
eJHaem.  2 (2021)  1 - p. 81-93 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Second primary malignancies in chronic lymphocytic leukaemi..:

Shen, Yandong ; Coyle, Luke ; Kerridge, Ian...
eJHaem.  3 (2021)  1 - p. 129-138 , 2021
Link: https://doi.org/10.1002/..
 
?
14

Insight into del17p low‐frequency subclones in chronic lymp..:

Do, Cuc ; Best, O. Giles ; Thurgood, Lauren...
British Journal of Haematology.  193 (2021)  3 - p. 556-560 , 2021
Link: https://doi.org/10.1111/..
 
?
15

Using ibrutinib in earlier lines of treatment results in be..:

Woyach, Jennifer ; Tedeschi, Alessandra ; Munir, Talha...
Leukemia & Lymphoma.  62 (2021)  13 - p. 3278-3282 , 2021
Link: https://doi.org/10.1080/..
 
1-15